Ernexa Therapeutics (ERNAW) Exchange Rate Effect (2010 - 2020)
Ernexa Therapeutics' (ERNAW) quarterly Exchange Rate Effect came in at $1000.0 in Q4 2020, down 93.33% YoY from $15000.0 in Q1 2020, and up 101.41% on a QoQ basis from -$71000.0 in Q1 2020.
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Exchange Rate Effect (2010 - 2020) Analysis & Trends
Ernexa Therapeutics (ERNAW) has 11 years of Exchange Rate Effect data on file, last reported at $1000.0 in Q4 2020.
- Quarterly Exchange Rate Effect fell 93.33% year-over-year to $1000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$67000.0 (down 259.52% YoY) and the FY2020 annual result came in at $11000.0, down 73.81% from the prior year.
- Exchange Rate Effect rose to $1000.0 in Q4 2020, from -$71000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $53000.0 in Q1 2016 to a low of -$71000.0 in Q1 2020.
- A 5-year average of -$941.18 and a median of $1000.0 in 2020 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2017 — Exchange Rate Effect soared 450.0% — and 2018, when it tumbled 571.43%.
- Tracing ERNAW's Exchange Rate Effect over 5 years: stood at -$17000.0 in 2016, then jumped by 58.82% to -$7000.0 in 2017, then plunged by 571.43% to -$47000.0 in 2018, then jumped by 131.91% to $15000.0 in 2019, then plunged by 93.33% to $1000.0 in 2020.
- The last three Exchange Rate Effect figures came in at $1000.0 (Q4 2020), -$71000.0 (Q1 2020), and $15000.0 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 1,000.00 |
| Mar 31, 2020 | -71,000.00 |
| Dec 31, 2019 | 15,000.00 |
| Sep 30, 2019 | -12,000.00 |
| Jun 30, 2019 | 20,000.00 |
| Mar 31, 2019 | 19,000.00 |
| Dec 31, 2018 | -47,000.00 |
| Sep 30, 2018 | 21,000.00 |
| Jun 30, 2018 | -24,000.00 |
| Mar 31, 2018 | -25,000.00 |
| Dec 31, 2017 | -7,000.00 |
| Sep 30, 2017 | 42,000.00 |
| Jun 30, 2017 | 21,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Dec 31, 2016 | -17,000.00 |
| Sep 30, 2016 | -12,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Dec 31, 2015 | -24,000.00 |
| Sep 30, 2015 | -67,000.00 |
| Jun 30, 2015 | -100,000.00 |